Search results
Clinical trials show promise in treating central n | Newswise
Newswise· 7 days agoDana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lym
Spanish Diagnostic Firm Amadix Prepares for US Launch of Liquid Biopsy CRC Test
GenomeWeb News· 2 days agoWith new results validating its PreveCol liquid biopsy test for colorectal cancer, Spanish diagnostic company Amadix is preparing for the US launch of its screening assay. In data presented ...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 2 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Are You Getting Enough Iodine From Your Diet?
Mercola· 4 days agoUnfortunately, data collected by the U.S. National Health and Nutrition Examination Survey has revealed a significant drop in median urine iodine values.1 The median iodine level measured in ...
Chuck D Calls Out Rappers Over 40 For Spreading Negativity
HotNewHipHop· 3 days agoChuck D is one of the most outspoken artists in history. The only thing the rapper hates more than injustice, however, is other rappers who spread negativity throughout the music industry. Especially ...
The Evolution of Vaccinology: From Humble Beginnings to Advanced Science | JD Supra
JD Supra· 2 days agoFor centuries, humans have sought ways to protect from deadly diseases. The practice of intentionally exposing healthy people to smallpox, a practice...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Forrest City Times-Herald· 4 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...